Bell Investment Advisors’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
IA
MCI
HNB
Bell Investment Advisors's AMED Position: Q3 2025 in Review
Bell Investment Advisors sold out of Amedisys (AMED) in Q3 2025, closing a stake of 200 shares — an estimated $19.7K sold.
Bell Investment Advisors first reported a position in AMED in Q3 2021 and held it in 15 quarters. The position peaked at $19.7K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- Bell Investment Advisors reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- Bell Investment Advisors sold 200 Amedisys shares in Q3 2025, an estimated $19.7K.
- Bell Investment Advisors first reported a position in Amedisys in Q3 2021 and held it in 15 quarters.
- Bell Investment Advisors's Amedisys position peaked at $19.7K in Q2 2025.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on Bell Investment Advisors's 13F filing for Q3 2025, filed 21 Nov 2025.